Full Name | Dr Sapna Jain |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 30 Years |
Location | 805 Inman Ave, Colonia, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568415990 | NPI | - | NPPES |
0146757 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA07300600 (New Jersey) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inman Medical Associates,llc | 5698864528 | 3 |
News Archive
The dead swan found in Fife in Scotland on March 29th has now been identified by DNA tests as one of a migratory species, quelling fears that it was the harbinger of the first outbreak in the UK.
Several news organization have "fact checks" on the reconciliation procedure and health reform provisions.
Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
› Verified 4 days ago
Entity Name | Inman Medical Associates,llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073702205 PECOS PAC ID: 5698864528 Enrollment ID: O20071130000140 |
News Archive
The dead swan found in Fife in Scotland on March 29th has now been identified by DNA tests as one of a migratory species, quelling fears that it was the harbinger of the first outbreak in the UK.
Several news organization have "fact checks" on the reconciliation procedure and health reform provisions.
Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sapna Jain, MD 1024 Park Ave, Suite 6a, Plainfield, NJ 07060 Ph: (908) 222-8400 | Dr Sapna Jain, MD 805 Inman Ave, Colonia, NJ 07067 Ph: (732) 340-0007 |
News Archive
The dead swan found in Fife in Scotland on March 29th has now been identified by DNA tests as one of a migratory species, quelling fears that it was the harbinger of the first outbreak in the UK.
Several news organization have "fact checks" on the reconciliation procedure and health reform provisions.
Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
› Verified 4 days ago
Dr. Raul Allarey Limjuco, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 411 New Dover Rd, Colonia, NJ 07067 Phone: 732-388-9269 | |
Stephen D Ford, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1503 St Georges Ave, Suite 201, Colonia, NJ 07067 Phone: 732-382-5200 Fax: 732-382-5201 |